SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-042894
Filing Date
2021-08-10
Accepted
2021-08-10 08:04:55
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-10q_20210630.htm   iXBRL 10-Q 2116283
2 EX-10.1 vrca-ex101_9.htm EX-10.1 21072
3 EX-31.1 vrca-ex311_8.htm EX-31.1 17019
4 EX-31.2 vrca-ex312_6.htm EX-31.2 16942
5 EX-32.1 vrca-ex321_7.htm EX-32.1 11216
  Complete submission text file 0001564590-21-042894.txt   7465536

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vrca-20210630.xsd EX-101.SCH 44206
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vrca-20210630_cal.xml EX-101.CAL 55580
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vrca-20210630_def.xml EX-101.DEF 146762
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20210630_lab.xml EX-101.LAB 388407
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20210630_pre.xml EX-101.PRE 278035
11 EXTRACTED XBRL INSTANCE DOCUMENT vrca-10q_20210630_htm.xml XML 1430734
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 211158479
SIC: 2834 Pharmaceutical Preparations